Paper20009288
Glucose deprivation-induced metabolic oxidative stress and cancer therapy.
Simons AL and 3 others. J Cancer Res Ther, 2009. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Glucose deprivation-induced metabolic oxidative stress and cancer therapy. Papers, record 20009288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20009288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucose | Major topic |
| Neoplasms | Major topic |
| Oxidative Stress | Major topic |
| Animals | |
| Glycolysis | |
| Humans |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 CA134941 | NCI NIH HHS | United States | K01CA134941 | PubMed and NIH | NIH RePORTER |
| R01 CA133114 | NCI NIH HHS | United States | R01CA133114 | PubMed and NIH | NIH RePORTER |
| P30 CA086862 | NCI NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| R01-CA100045 | NCI NIH HHS | United States | R01CA100045 | PubMed and NIH | NIH RePORTER |
| R01 CA100045 | NCI NIH HHS | United States | R01CA100045 | PubMed and NIH | NIH RePORTER |
| P30-CA086862 | NCI NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| P01-CA66081 | NCI NIH HHS | United States | P01CA066081 | PubMed and NIH | NIH RePORTER |
| P01 CA066081 | NCI NIH HHS | United States | P01CA066081 | PubMed and NIH | NIH RePORTER |
| R01-CA133114 | NCI NIH HHS | United States | R01CA133114 | PubMed and NIH | NIH RePORTER |
| T32 CA078586 | NCI NIH HHS | United States | T32CA078586 | PubMed and NIH | NIH RePORTER |
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14601097 | Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. | Cancer | 2003 | https://conductscience.org/library/papers/14601097 | PubMed |
| 2 | 18937644 | Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. | Biochem J | 2009 | https://conductscience.org/library/papers/18937644 | PubMed |
| 3 | 7593239 | Contribution of increased glutathione content to mechanisms of oxidative stress resistance in hydrogen peroxide resistant hamster fibroblasts. | J Cell Physiol | 1995 | https://conductscience.org/library/papers/7593239 | PubMed |
| 4 | 11429233 | Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. | Int J Radiat Oncol Biol Phys | 2001 | https://conductscience.org/library/papers/11429233 | PubMed |
| 5 | 11754496 | F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. | Head Neck | 2001 | https://conductscience.org/library/papers/11754496 | PubMed |
| 6 | 15275712 | Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. | Int J Radiat Oncol Biol Phys | 2004 | https://conductscience.org/library/papers/15275712 | PubMed |
| 7 | 12810678 | 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. | Cancer Res | 2003 | https://conductscience.org/library/papers/12810678 | PubMed |
| 8 | 11754497 | Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. | Head Neck | 2001 | https://conductscience.org/library/papers/11754497 | PubMed |
| 9 | 11891942 | FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. | Head Neck | 2002 | https://conductscience.org/library/papers/11891942 | PubMed |
| 10 | 12170026 | Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. | Ann Surg | 2002 | https://conductscience.org/library/papers/12170026 | PubMed |
| 11 | 11870529 | FDG-PET. A possible prognostic factor in head and neck cancer. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11870529 | PubMed |
| 12 | 8641905 | Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. | Int J Radiat Oncol Biol Phys | 1996 | https://conductscience.org/library/papers/8641905 | PubMed |
| 13 | 12783586 | Toxicity of platinum compounds. | Expert Opin Pharmacother | 2003 | https://conductscience.org/library/papers/12783586 | PubMed |
| 14 | 10776978 | Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. | Am J Clin Oncol | 2000 | https://conductscience.org/library/papers/10776978 | PubMed |
| 15 | 15374989 | Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. | Cancer Res | 2004 | https://conductscience.org/library/papers/15374989 | PubMed |
| 16 | 3875573 | Non-nitro radiation sensitizers. | Int J Radiat Biol Relat Stud Phys Chem Med | 1985 | https://conductscience.org/library/papers/3875573 | PubMed |
| 17 | 11909699 | Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. | Free Radic Biol Med | 2002 | https://conductscience.org/library/papers/11909699 | PubMed |
| 19 | 14623746 | Staging of head and neck squamous cell cancer with extended-field FDG-PET. | Arch Otolaryngol Head Neck Surg | 2003 | https://conductscience.org/library/papers/14623746 | PubMed |
| 20 | 15590172 | Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. | Int J Radiat Oncol Biol Phys | 2004 | https://conductscience.org/library/papers/15590172 | PubMed |
| 21 | 14576837 | Cisplatin: mode of cytotoxic action and molecular basis of resistance. | Oncogene | 2003 | https://conductscience.org/library/papers/14576837 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41213437 | Redox regulation of cell migration via Nischarin S-glutathionylation. | Free Radic Biol Med | 2026 | https://conductscience.org/library/papers/41213437 | PubMed |
| 41040280 | Redox Regulation of Cell Migration via Nischarin S-glutathionylation. | bioRxiv | 2025 | https://conductscience.org/library/papers/41040280 | PubMed |
| 38785550 | Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38785550 | PubMed |
| 38020920 | The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/38020920 | PubMed |
| 37636066 | Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment. | iScience | 2023 | https://conductscience.org/library/papers/37636066 | PubMed |
| 37377905 | Flux estimation analysis systematically characterizes the metabolic shifts of the central metabolism pathway in human cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/37377905 | PubMed |
| 37259067 | Disulfidptosis: a new form of programmed cell death. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37259067 | PubMed |
| 36867944 | Real-time redox adaptations in human airway epithelial cells exposed to isoprene hydroxy hydroperoxide. | Redox Biol | 2023 | https://conductscience.org/library/papers/36867944 | PubMed |
| 35768428 | GLUT1 production in cancer cells: a tragedy of the commons. | NPJ Syst Biol Appl | 2022 | https://conductscience.org/library/papers/35768428 | PubMed |
| 35530337 | The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. | Front Oncol | 2022 | https://conductscience.org/library/papers/35530337 | PubMed |
| 34811508 | Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer. | Br J Cancer | 2022 | https://conductscience.org/library/papers/34811508 | PubMed |
| 33965513 | Metabolic reprogramming in renal cancer: Events of a metabolic disease. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33965513 | PubMed |
| 33802597 | Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33802597 | PubMed |
| 33561488 | N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity. | Free Radic Biol Med | 2021 | https://conductscience.org/library/papers/33561488 | PubMed |
| 33549532 | Structural and functional remodeling of mitochondria as an adaptive response to energy deprivation. | Biochim Biophys Acta Bioenerg | 2021 | https://conductscience.org/library/papers/33549532 | PubMed |
| 33530098 | Metabolic Strategies for Inhibiting Cancer Development. | Adv Nutr | 2021 | https://conductscience.org/library/papers/33530098 | PubMed |
| 31612140 | 2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation. | Front Mol Biosci | 2019 | https://conductscience.org/library/papers/31612140 | PubMed |
| 31301065 | Stress granule: A promising target for cancer treatment. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/31301065 | PubMed |
| 30936596 | Induction of Apoptosis by a Combination of 2-Deoxyglucose and Metformin in Esophageal Squamous Cell Carcinoma by Targeting Cancer Cell Metabolism. | Iran J Med Sci | 2019 | https://conductscience.org/library/papers/30936596 | PubMed |
| 30382544 | Prophylactic effect of ethyl pyruvate on renal ischemia/reperfusion injury mediated through oxidative stress. | Int Urol Nephrol | 2019 | https://conductscience.org/library/papers/30382544 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCLC | 2729 | PubTator's text mining | https://conductscience.org/library/genes/2729 | NCBI Gene |
| GSR | 2936 | PubTator's text mining | https://conductscience.org/library/genes/2936 | NCBI Gene |
| HK1 | 3098 | PubTator's text mining | https://conductscience.org/library/genes/3098 | NCBI Gene |
| PRDX5 | 25824 | PubTator's text mining | https://conductscience.org/library/genes/25824 | NCBI Gene |
| TXN | 7295 | PubTator's text mining | https://conductscience.org/library/genes/7295 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20009288
GET https://conductscience.org/api/papers/v1/20009288/references?page=2